JANIS RULE: Open Payments
NPI 1518274760 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 25 payments from 8 companies in 2025. Trend: 2023 $1,585 · 2024 $907 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $171 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Indivior Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, FANAPT, CAPLYTA, AUSTEDO XR, SUBLOCADE, ARISTADA.
Industry payments across WV — which companies pay providers there.
